Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Parexel Execs On Trials In War Zones, Biotech ‘Green Shoots’, China Action And DCT Rework
Mar 09 2026
•
By
Anju Ghangurde
Parexel’s CEO Peyton Howell and India country head, Sanjay Vyas
(Parexel)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Regional Comparisons
More from Pink Sheet